Cargando…
Computational design of fusion proteins against ErbB2-amplified tumors inspired by ricin toxin
Although the anti-cancer activity of ricin is well-known, its non-specific targeting challenges the development of ricin-derived medicines. In the present study, novel potential ribosome-inactivating fusion proteins (RIPs) were computationally engineered by incorporation of an ErbB2-dependant penetr...
Autores principales: | Ahmadi Moghaddam, Yasser, Maroufi, Asad, Zareei, Sara, Irani, Mehdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018397/ https://www.ncbi.nlm.nih.gov/pubmed/36936983 http://dx.doi.org/10.3389/fmolb.2023.1098365 |
Ejemplares similares
-
Progress in the Research and Targeted Therapy of ErbB/HER Receptors in Urothelial Bladder Cancer
por: Chen, Dong, et al.
Publicado: (2021) -
m(5)C RNA Methylation Primarily Affects the ErbB and PI3K–Akt Signaling Pathways in Gastrointestinal Cancer
por: Xiang, Shixin, et al.
Publicado: (2020) -
Peptides Targeting the Interaction Between Erb1 and Ytm1 Ribosome Assembly Factors
por: Orea-Ordóñez, Lidia, et al.
Publicado: (2021) -
ErbB2 and bone sialoprotein as markers for metastatic osteosarcoma cells
por: Valabrega, G, et al.
Publicado: (2003) -
The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer
por: de Graeff, P, et al.
Publicado: (2008)